生物製剤およびバイオ後続品の世界市場:販売動向2017

QYResearchが発行した調査報告書(QYR7050764)
◆英語タイトル:Global Biologics and Biosimilars Sales Market Report 2017
◆商品コード:QYR7050764
◆発行会社(リサーチ会社):QYResearch
◆発行日:2017年4月27日
◆ページ数:122
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD8,000 ⇒換算¥864,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、生物製剤およびバイオ後続品のグローバル市場について調査・分析し、生物製剤およびバイオ後続品のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、生物製剤およびバイオ後続品産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・生物製剤およびバイオ後続品市場概要
・生物製剤およびバイオ後続品のメーカー別販売量・メーカー別シェア
・生物製剤およびバイオ後続品の世界市場:種類別販売量・市場シェア
・生物製剤およびバイオ後続品の世界市場:用途別販売量・市場シェア
・生物製剤およびバイオ後続品の世界市場:地域別販売量・市場シェア
・生物製剤およびバイオ後続品の米国市場規模
・生物製剤およびバイオ後続品の中国市場規模
・生物製剤およびバイオ後続品の欧州市場規模
・生物製剤およびバイオ後続品の日本市場規模
・生物製剤およびバイオ後続品の東南アジア市場規模
・生物製剤およびバイオ後続品のインド市場規模
・生物製剤およびバイオ後続品のメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・生物製剤およびバイオ後続品のコスト分析・価格動向
・生物製剤およびバイオ後続品の産業チェーン(サプライチェーン分析)
・生物製剤およびバイオ後続品のマーケティング戦略・販売チャネル、流通業者
・生物製剤およびバイオ後続品市場への影響要因分析
・生物製剤およびバイオ後続品の世界市場予測
・生物製剤およびバイオ後続品のアメリカ市場予測
・生物製剤およびバイオ後続品の中国市場予測
・生物製剤およびバイオ後続品のヨーロッパ市場予測
・生物製剤およびバイオ後続品の日本市場予測
・生物製剤およびバイオ後続品の東南アジア市場予測
・生物製剤およびバイオ後続品のインド市場予測
・生物製剤およびバイオ後続品の種類別世界市場予測
・生物製剤およびバイオ後続品の用途別世界市場予測
...
【レポートの概要】

In this report, the global Biologics and Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Biologics and Biosimilars for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Biologics and Biosimilars market competition by top manufacturers/players, with Biologics and Biosimilars sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Novo Nordisk
Novartis
Merck
Lilly
3sbio
Changchun High Tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
Sandoz
Teva
Hospira
Mylan
3sbio
Changchun High Tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
Antibiotic
Enzyme
Hormone
Non-Patented Biological Reagents
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Biologics and Biosimilars for each application, including
Tumor
Diabetes
Cardiovascular
Hemophilia
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global Biologics and Biosimilars Sales Market Report 2017
1 Biologics and Biosimilars Market Overview
1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Classification of Biologics and Biosimilars by Product Category
1.2.1 Global Biologics and Biosimilars Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Biologics and Biosimilars Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Antibiotic
1.2.4 Enzyme
1.2.5 Hormone
1.2.6 Non-Patented Biological Reagents
1.2.7 Other
1.3 Global Biologics and Biosimilars Market by Application/End Users
1.3.1 Global Biologics and Biosimilars Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Global Biologics and Biosimilars Market by Region
1.4.1 Global Biologics and Biosimilars Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Biologics and Biosimilars Status and Prospect (2012-2022)
1.4.3 China Biologics and Biosimilars Status and Prospect (2012-2022)
1.4.4 Europe Biologics and Biosimilars Status and Prospect (2012-2022)
1.4.5 Japan Biologics and Biosimilars Status and Prospect (2012-2022)
1.4.6 Southeast Asia Biologics and Biosimilars Status and Prospect (2012-2022)
1.4.7 India Biologics and Biosimilars Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Biologics and Biosimilars (2012-2022)
1.5.1 Global Biologics and Biosimilars Sales and Growth Rate (2012-2022)
1.5.2 Global Biologics and Biosimilars Revenue and Growth Rate (2012-2022)

2 Global Biologics and Biosimilars Competition by Players/Suppliers, Type and Application
2.1 Global Biologics and Biosimilars Market Competition by Players/Suppliers
2.1.1 Global Biologics and Biosimilars Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Biologics and Biosimilars Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Biologics and Biosimilars (Volume and Value) by Type
2.2.1 Global Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
2.2.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
2.3 Global Biologics and Biosimilars (Volume and Value) by Region
2.3.1 Global Biologics and Biosimilars Sales and Market Share by Region (2012-2017)
2.3.2 Global Biologics and Biosimilars Revenue and Market Share by Region (2012-2017)
2.4 Global Biologics and Biosimilars (Volume) by Application

3 United States Biologics and Biosimilars (Volume, Value and Sales Price)
3.1 United States Biologics and Biosimilars Sales and Value (2012-2017)
3.1.1 United States Biologics and Biosimilars Sales and Growth Rate (2012-2017)
3.1.2 United States Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
3.1.3 United States Biologics and Biosimilars Sales Price Trend (2012-2017)
3.2 United States Biologics and Biosimilars Sales Volume and Market Share by Players
3.3 United States Biologics and Biosimilars Sales Volume and Market Share by Type
3.4 United States Biologics and Biosimilars Sales Volume and Market Share by Application

4 China Biologics and Biosimilars (Volume, Value and Sales Price)
4.1 China Biologics and Biosimilars Sales and Value (2012-2017)
4.1.1 China Biologics and Biosimilars Sales and Growth Rate (2012-2017)
4.1.2 China Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
4.1.3 China Biologics and Biosimilars Sales Price Trend (2012-2017)
4.2 China Biologics and Biosimilars Sales Volume and Market Share by Players
4.3 China Biologics and Biosimilars Sales Volume and Market Share by Type
4.4 China Biologics and Biosimilars Sales Volume and Market Share by Application

5 Europe Biologics and Biosimilars (Volume, Value and Sales Price)
5.1 Europe Biologics and Biosimilars Sales and Value (2012-2017)
5.1.1 Europe Biologics and Biosimilars Sales and Growth Rate (2012-2017)
5.1.2 Europe Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
5.1.3 Europe Biologics and Biosimilars Sales Price Trend (2012-2017)
5.2 Europe Biologics and Biosimilars Sales Volume and Market Share by Players
5.3 Europe Biologics and Biosimilars Sales Volume and Market Share by Type
5.4 Europe Biologics and Biosimilars Sales Volume and Market Share by Application

6 Japan Biologics and Biosimilars (Volume, Value and Sales Price)
6.1 Japan Biologics and Biosimilars Sales and Value (2012-2017)
6.1.1 Japan Biologics and Biosimilars Sales and Growth Rate (2012-2017)
6.1.2 Japan Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
6.1.3 Japan Biologics and Biosimilars Sales Price Trend (2012-2017)
6.2 Japan Biologics and Biosimilars Sales Volume and Market Share by Players
6.3 Japan Biologics and Biosimilars Sales Volume and Market Share by Type
6.4 Japan Biologics and Biosimilars Sales Volume and Market Share by Application

7 Southeast Asia Biologics and Biosimilars (Volume, Value and Sales Price)
7.1 Southeast Asia Biologics and Biosimilars Sales and Value (2012-2017)
7.1.1 Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Biologics and Biosimilars Sales Price Trend (2012-2017)
7.2 Southeast Asia Biologics and Biosimilars Sales Volume and Market Share by Players
7.3 Southeast Asia Biologics and Biosimilars Sales Volume and Market Share by Type
7.4 Southeast Asia Biologics and Biosimilars Sales Volume and Market Share by Application

8 India Biologics and Biosimilars (Volume, Value and Sales Price)
8.1 India Biologics and Biosimilars Sales and Value (2012-2017)
8.1.1 India Biologics and Biosimilars Sales and Growth Rate (2012-2017)
8.1.2 India Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
8.1.3 India Biologics and Biosimilars Sales Price Trend (2012-2017)
8.2 India Biologics and Biosimilars Sales Volume and Market Share by Players
8.3 India Biologics and Biosimilars Sales Volume and Market Share by Type
8.4 India Biologics and Biosimilars Sales Volume and Market Share by Application

9 Global Biologics and Biosimilars Players/Suppliers Profiles and Sales Data
9.1 Pfizer
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Biologics and Biosimilars Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Roche
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Biologics and Biosimilars Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Amgen
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Biologics and Biosimilars Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 AbbVie
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Biologics and Biosimilars Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Sanofi
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Biologics and Biosimilars Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Johnson & Johnson
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Biologics and Biosimilars Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Novo Nordisk
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Biologics and Biosimilars Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Novartis
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Biologics and Biosimilars Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Merck
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Biologics and Biosimilars Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Merck Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Lilly
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Biologics and Biosimilars Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Lilly Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 3sbio
9.12 Changchun High Tech
9.13 CP Guojian Pharmacy
9.14 Biotech Pharma
9.15 Gelgen Biopharma
9.16 Sandoz
9.17 Teva
9.18 Hospira
9.19 Mylan
9.20 3sbio
9.21 Changchun High Tech
9.22 CP Guojian Pharmacy
9.23 Biotech Pharma
9.24 Gelgen Biopharma

10 Biologics and Biosimilars Maufacturing Cost Analysis
10.1 Biologics and Biosimilars Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Biologics and Biosimilars
10.3 Manufacturing Process Analysis of Biologics and Biosimilars

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Biologics and Biosimilars Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Biologics and Biosimilars Market Forecast (2017-2022)
14.1 Global Biologics and Biosimilars Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Biologics and Biosimilars Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Biologics and Biosimilars Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Biologics and Biosimilars Price and Trend Forecast (2017-2022)
14.2 Global Biologics and Biosimilars Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Biologics and Biosimilars Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Biologics and Biosimilars Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Biologics and Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Biologics and Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Biologics and Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Biologics and Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Biologics and Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Biologics and Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Biologics and Biosimilars Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Biologics and Biosimilars Sales Forecast by Type (2017-2022)
14.3.2 Global Biologics and Biosimilars Revenue Forecast by Type (2017-2022)
14.3.3 Global Biologics and Biosimilars Price Forecast by Type (2017-2022)
14.4 Global Biologics and Biosimilars Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Biologics and Biosimilars
Figure Global Biologics and Biosimilars Sales Volume Comparison (K MT) by Type (2012-2022)
Figure Global Biologics and Biosimilars Sales Volume Market Share by Type (Product Category) in 2016
Figure Antibiotic Product Picture
Figure Enzyme Product Picture
Figure Hormone Product Picture
Figure Non-Patented Biological Reagents Product Picture
Figure Other Product Picture
Figure Global Biologics and Biosimilars Sales Comparison (K MT) by Application (2012-2022)
Figure Global Sales Market Share of Biologics and Biosimilars by Application in 2016
Figure Tumor Examples
Figure Diabetes Examples
Figure Cardiovascular Examples
Figure Hemophilia Examples
Figure Other Examples
Figure Global Biologics and Biosimilars Market Size (Million USD) by Regions (2012-2022)
Figure United States Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Biologics and Biosimilars Sales Volume (K MT) and Growth Rate (2012-2022)
Figure Global Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Biologics and Biosimilars Sales Volume (K MT) (2012-2017)
Table Global Biologics and Biosimilars Sales (K MT) of Key Players/Suppliers (2012-2017)
Table Global Biologics and Biosimilars Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Biologics and Biosimilars Sales Share by Players/Suppliers
Figure 2017 Biologics and Biosimilars Sales Share by Players/Suppliers
Figure Global Biologics and Biosimilars Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Biologics and Biosimilars Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Biologics and Biosimilars Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Biologics and Biosimilars Revenue Share by Players
Table 2017 Global Biologics and Biosimilars Revenue Share by Players
Table Global Biologics and Biosimilars Sales (K MT) and Market Share by Type (2012-2017)
Table Global Biologics and Biosimilars Sales Share (K MT) by Type (2012-2017)
Figure Sales Market Share of Biologics and Biosimilars by Type (2012-2017)
Figure Global Biologics and Biosimilars Sales Growth Rate by Type (2012-2017)
Table Global Biologics and Biosimilars Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Biologics and Biosimilars Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biologics and Biosimilars by Type (2012-2017)
Figure Global Biologics and Biosimilars Revenue Growth Rate by Type (2012-2017)
Table Global Biologics and Biosimilars Sales Volume (K MT) and Market Share by Region (2012-2017)
Table Global Biologics and Biosimilars Sales Share by Region (2012-2017)
Figure Sales Market Share of Biologics and Biosimilars by Region (2012-2017)
Figure Global Biologics and Biosimilars Sales Growth Rate by Region in 2016
Table Global Biologics and Biosimilars Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Biologics and Biosimilars Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Biologics and Biosimilars by Region (2012-2017)
Figure Global Biologics and Biosimilars Revenue Growth Rate by Region in 2016
Table Global Biologics and Biosimilars Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Biologics and Biosimilars Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Biologics and Biosimilars by Region (2012-2017)
Figure Global Biologics and Biosimilars Revenue Market Share by Region in 2016
Table Global Biologics and Biosimilars Sales Volume (K MT) and Market Share by Application (2012-2017)
Table Global Biologics and Biosimilars Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Biologics and Biosimilars by Application (2012-2017)
Figure Global Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure United States Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure United States Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Biologics and Biosimilars Sales Price (USD/MT) Trend (2012-2017)
Table United States Biologics and Biosimilars Sales Volume (K MT) by Players (2012-2017)
Table United States Biologics and Biosimilars Sales Volume Market Share by Players (2012-2017)
Figure United States Biologics and Biosimilars Sales Volume Market Share by Players in 2016
Table United States Biologics and Biosimilars Sales Volume (K MT) by Type (2012-2017)
Table United States Biologics and Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure United States Biologics and Biosimilars Sales Volume Market Share by Type in 2016
Table United States Biologics and Biosimilars Sales Volume (K MT) by Application (2012-2017)
Table United States Biologics and Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure United States Biologics and Biosimilars Sales Volume Market Share by Application in 2016
Figure China Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Biologics and Biosimilars Sales Price (USD/MT) Trend (2012-2017)
Table China Biologics and Biosimilars Sales Volume (K MT) by Players (2012-2017)
Table China Biologics and Biosimilars Sales Volume Market Share by Players (2012-2017)
Figure China Biologics and Biosimilars Sales Volume Market Share by Players in 2016
Table China Biologics and Biosimilars Sales Volume (K MT) by Type (2012-2017)
Table China Biologics and Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure China Biologics and Biosimilars Sales Volume Market Share by Type in 2016
Table China Biologics and Biosimilars Sales Volume (K MT) by Application (2012-2017)
Table China Biologics and Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure China Biologics and Biosimilars Sales Volume Market Share by Application in 2016
Figure Europe Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Biologics and Biosimilars Sales Price (USD/MT) Trend (2012-2017)
Table Europe Biologics and Biosimilars Sales Volume (K MT) by Players (2012-2017)
Table Europe Biologics and Biosimilars Sales Volume Market Share by Players (2012-2017)
Figure Europe Biologics and Biosimilars Sales Volume Market Share by Players in 2016
Table Europe Biologics and Biosimilars Sales Volume (K MT) by Type (2012-2017)
Table Europe Biologics and Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure Europe Biologics and Biosimilars Sales Volume Market Share by Type in 2016
Table Europe Biologics and Biosimilars Sales Volume (K MT) by Application (2012-2017)
Table Europe Biologics and Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure Europe Biologics and Biosimilars Sales Volume Market Share by Application in 2016
Figure Japan Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Japan Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Biologics and Biosimilars Sales Price (USD/MT) Trend (2012-2017)
Table Japan Biologics and Biosimilars Sales Volume (K MT) by Players (2012-2017)
Table Japan Biologics and Biosimilars Sales Volume Market Share by Players (2012-2017)
Figure Japan Biologics and Biosimilars Sales Volume Market Share by Players in 2016
Table Japan Biologics and Biosimilars Sales Volume (K MT) by Type (2012-2017)
Table Japan Biologics and Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure Japan Biologics and Biosimilars Sales Volume Market Share by Type in 2016
Table Japan Biologics and Biosimilars Sales Volume (K MT) by Application (2012-2017)
Table Japan Biologics and Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure Japan Biologics and Biosimilars Sales Volume Market Share by Application in 2016
Figure Southeast Asia Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Southeast Asia Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Biologics and Biosimilars Sales Price (USD/MT) Trend (2012-2017)
Table Southeast Asia Biologics and Biosimilars Sales Volume (K MT) by Players (2012-2017)
Table Southeast Asia Biologics and Biosimilars Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Biologics and Biosimilars Sales Volume Market Share by Players in 2016
Table Southeast Asia Biologics and Biosimilars Sales Volume (K MT) by Type (2012-2017)
Table Southeast Asia Biologics and Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Biologics and Biosimilars Sales Volume Market Share by Type in 2016
Table Southeast Asia Biologics and Biosimilars Sales Volume (K MT) by Application (2012-2017)
Table Southeast Asia Biologics and Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Biologics and Biosimilars Sales Volume Market Share by Application in 2016
Figure India Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure India Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Biologics and Biosimilars Sales Price (USD/MT) Trend (2012-2017)
Table India Biologics and Biosimilars Sales Volume (K MT) by Players (2012-2017)
Table India Biologics and Biosimilars Sales Volume Market Share by Players (2012-2017)
Figure India Biologics and Biosimilars Sales Volume Market Share by Players in 2016
Table India Biologics and Biosimilars Sales Volume (K MT) by Type (2012-2017)
Table India Biologics and Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure India Biologics and Biosimilars Sales Volume Market Share by Type in 2016
Table India Biologics and Biosimilars Sales Volume (K MT) by Application (2012-2017)
Table India Biologics and Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure India Biologics and Biosimilars Sales Volume Market Share by Application in 2016
Table Pfizer Basic Information List
Table Pfizer Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Biologics and Biosimilars Sales Growth Rate (2012-2017)
Figure Pfizer Biologics and Biosimilars Sales Global Market Share (2012-2017
Figure Pfizer Biologics and Biosimilars Revenue Global Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Roche Biologics and Biosimilars Sales Growth Rate (2012-2017)
Figure Roche Biologics and Biosimilars Sales Global Market Share (2012-2017
Figure Roche Biologics and Biosimilars Revenue Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Amgen Biologics and Biosimilars Sales Growth Rate (2012-2017)
Figure Amgen Biologics and Biosimilars Sales Global Market Share (2012-2017
Figure Amgen Biologics and Biosimilars Revenue Global Market Share (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AbbVie Biologics and Biosimilars Sales Growth Rate (2012-2017)
Figure AbbVie Biologics and Biosimilars Sales Global Market Share (2012-2017
Figure AbbVie Biologics and Biosimilars Revenue Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Biologics and Biosimilars Sales Growth Rate (2012-2017)
Figure Sanofi Biologics and Biosimilars Sales Global Market Share (2012-2017
Figure Sanofi Biologics and Biosimilars Revenue Global Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson & Johnson Biologics and Biosimilars Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Biologics and Biosimilars Sales Global Market Share (2012-2017
Figure Johnson & Johnson Biologics and Biosimilars Revenue Global Market Share (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novo Nordisk Biologics and Biosimilars Sales Growth Rate (2012-2017)
Figure Novo Nordisk Biologics and Biosimilars Sales Global Market Share (2012-2017
Figure Novo Nordisk Biologics and Biosimilars Revenue Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Biologics and Biosimilars Sales Growth Rate (2012-2017)
Figure Novartis Biologics and Biosimilars Sales Global Market Share (2012-2017
Figure Novartis Biologics and Biosimilars Revenue Global Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Merck Biologics and Biosimilars Sales Growth Rate (2012-2017)
Figure Merck Biologics and Biosimilars Sales Global Market Share (2012-2017
Figure Merck Biologics and Biosimilars Revenue Global Market Share (2012-2017)
Table Lilly Basic Information List
Table Lilly Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Lilly Biologics and Biosimilars Sales Growth Rate (2012-2017)
Figure Lilly Biologics and Biosimilars Sales Global Market Share (2012-2017
Figure Lilly Biologics and Biosimilars Revenue Global Market Share (2012-2017)
Table 3sbio Basic Information List
Table Changchun High Tech Basic Information List
Table CP Guojian Pharmacy Basic Information List
Table Biotech Pharma Basic Information List
Table Gelgen Biopharma Basic Information List
Table Sandoz Basic Information List
Table Teva Basic Information List
Table Hospira Basic Information List
Table Mylan Basic Information List
Table 3sbio Basic Information List
Table Changchun High Tech Basic Information List
Table CP Guojian Pharmacy Basic Information List
Table Biotech Pharma Basic Information List
Table Gelgen Biopharma Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics and Biosimilars
Figure Manufacturing Process Analysis of Biologics and Biosimilars
Figure Biologics and Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics and Biosimilars Major Players in 2016
Table Major Buyers of Biologics and Biosimilars
Table Distributors/Traders List
Figure Global Biologics and Biosimilars Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Global Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Biologics and Biosimilars Price (USD/MT) and Trend Forecast (2017-2022)
Table Global Biologics and Biosimilars Sales Volume (K MT) Forecast by Regions (2017-2022)
Figure Global Biologics and Biosimilars Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Biologics and Biosimilars Sales Volume Market Share Forecast by Regions in 2022
Table Global Biologics and Biosimilars Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Biologics and Biosimilars Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Biologics and Biosimilars Revenue Market Share Forecast by Regions in 2022
Figure United States Biologics and Biosimilars Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Biologics and Biosimilars Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure China Biologics and Biosimilars Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Biologics and Biosimilars Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Europe Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Biologics and Biosimilars Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Japan Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Biologics and Biosimilars Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Biologics and Biosimilars Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure India Biologics and Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Biologics and Biosimilars Sales (K MT) Forecast by Type (2017-2022)
Figure Global Biologics and Biosimilars Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Biologics and Biosimilars Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Biologics and Biosimilars Revenue Market Share Forecast by Type (2017-2022)
Table Global Biologics and Biosimilars Price (USD/MT) Forecast by Type (2017-2022)
Table Global Biologics and Biosimilars Sales (K MT) Forecast by Application (2017-2022)
Figure Global Biologics and Biosimilars Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 生物製剤およびバイオ後続品の世界市場:販売動向2017(Global Biologics and Biosimilars Sales Market Report 2017)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆